🕵️ Amneal Pharmaceuticals, Inc. ($AMRX)
SEC insider & ownership activity, last 12 months · CIK 1723128 · every row links its SEC filing
Over the last 12 months insiders sold $9.8M with no open-market buying against it. Nikita Shah sold $4.1M in discretionary trades (Nov–Aug). 1 planned sale is pending, the largest $2.9M (Buchi J. Kevin). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 5 sellers, $9.8M (7 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Nikita Shah | 0 | – | 2 | $4.1M | Aug 12, 2026 |
| Jason B. Daly | 0 | – | 2 | $3.8M | Aug 12, 2026 |
| Kiely John | 0 | – | 1 | $882K | Aug 13, 2026 |
| Ted C. Nark | 0 | – | 1 | $586K | Nov 17, 2025 |
| Deborah M. Autor | 0 | – | 1 | $451K | May 11, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Tushar Patel | 17.6% | Class A | 13D | Aug 10, 2026 | filing ↗ |
| Chintu Patel | 9.4% | Class A | 13D | Aug 10, 2026 | filing ↗ |
| Chirag Patel | 8.4% | Class A | 13D | Aug 10, 2026 | filing ↗ |
| BlackRock, Inc. | 7.6% | 13G | Apr 27, 2026 | filing ↗ | |
| Akram Mahesh | 6.6% | 13G | May 14, 2025 | filing ↗ | |
| Patel Dipan | 5.4% | 13D | Dec 31, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| John Kiely | $880K | Aug 13, 2026 | filing ↗ |
| Nikita Shah | $2.6M | Aug 12, 2026 | filing ↗ |
| Buchi J. Kevin | $2.9M | Aug 11, 2026 | filing ↗ |
| Jason Daly | $3.6M | Aug 11, 2026 | filing ↗ |
| Deborah Autor | $450K | May 11, 2026 | filing ↗ |
| Ted C. Nark | $591K | Nov 17, 2025 | filing ↗ |
| Nikita Shah | $1.6M | Nov 12, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Aug 10, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Aug 10, 2026 | filing ↗ |
| New financial obligation (2.03) | Aug 10, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 10, 2026 | filing ↗ |
| Material agreement (1.01) | Aug 3, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jul 31, 2026 | filing ↗ |
| Earnings (2.02) | Jul 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 30, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 6, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 22, 2026 | filing ↗ |
| Earnings (2.02) | Apr 22, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 22, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 22, 2026 | filing ↗ |
| Earnings (2.02) | Feb 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 27, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 2, 2026 | filing ↗ |
| New financial obligation (2.03) | Feb 2, 2026 | filing ↗ |
| Other events (8.01) | Jan 23, 2026 | filing ↗ |
| Earnings (2.02) | Jan 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 13, 2026 | filing ↗ |
| Earnings (2.02) | Oct 30, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 30, 2025 | filing ↗ |